TTRAIL · Transferable Trustworthy Radiotherapy with Artificial Intelligence
„Хоризонт Европа“ — Действия „Мария Склодовска-Кюри“
- Период
- 2027-03-01 → 2031-02-28
- Финансиране от ЕС
- 4 720 182 €
- Участници
- 24
- Схема
- HORIZON-TMA-MSCA-DN
Линиите свързват координатора с партньорите. За проекти отпреди 2014 г. CORDIS не винаги дава точни координати. Тези точки са на ниво град или държава.
Накратко на български
Изкуственият интелект се прилага в радиотерапията, за да се персонализират дозите лъчение според биологията на всеки пациент. Това помага за повишаване на безопасността и точността на лечението, като намалява страничните ефекти и токсичността.
Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.
Цел на проекта
Cancer is the leading cause of death in Europe and the second worldwide. Over 50% of patients are treated with Radiotherapy (RT) and it accounts for 40% of cures, yet recurrence and toxicities remain significant challenges. Despite major advances in imaging, planning and delivery, RT still largely follows a “one-dose-fits-all” approach, leading to variable outcomes, toxicities and limited adaptability to patient-specific biology. Europe is currently undergoing a digital transformation driven by AI, advanced imaging and the European Health Data Space, but current AI solutions in RT remain fragmented, poorly generalizable and insufficiently explainable, preventing their safe deployment in clinical practice. TTRAIL aims at improving the safety, precision and personalization of radiotherapy (RT) by training 15 Doctoral Candidates as the first generation of Translational AI Radiotherapy Scientists, capable of uniting AI innovation with clinical radiotherapy, medical physics, regulatory science and digital-health translation. Their training will span multiscale data integration, uncertainty quantification, explainable and causal outcome modelling, digital twins and real-time adaptive dose delivery, aligned with the EU AI Act.The consortium unites top European universities, engineering schools, cancer centers and major industrial partners, providing access to cutting-edge RT platforms, large multicentre datasets and expertise across AI, imaging, oncology, physics and regulatory compliance. This intersectoral ecosystem ensures robust scientific training, clinical immersion, industrial exposure and strong open-science practices.By delivering a fully integrated, trust-by-design framework for AI-enabled Adaptive Radiotherapy, TTRAIL will produce highly skilled researchers able to lead the future of personalised, safe and explainable cancer treatment in Europe.
Оригинален текст от CORDIS (на английски).
Участници
- UNIVERSITE DE RENNES · RennesКоординаторФранция
- BRAINLAB SE · MUNCHENГермания
- CENTRE HOSPITALIER REGIONAL ET UNIVERSITAIRE DE BREST · BrestФранция
- Centre Eugène Marquis · RennesНиво градФранция
- DASSAULT SYSTEMES · VELIZY VILLACOUBLAYФранция
- ECOLE CENTRALE DE NANTES · Nantes Cedex 3Франция
- EMPRESA DE BASE TECNOLOGICA INTERNACIONAL DE CANARIAS, SOCIEDAD LIMITADA · LAS PALMAS DE GRAN CANARIAНиво градИспания
- EURECOM GIE · BiotФранция
- FONDAZIONE IRCCS ISTITUTO NAZIONALE DEI TUMORI · MilanИталия
- IDCQ HOSPITALES Y SANIDAD SL · MadridИспания
- INSTITUT MINES-TELECOM · PalaiseauФранция
- INSTITUTO TECNOLOGICO METROPOLITANO · MedellinКолумбия
- KARLSRUHER INSTITUT FUER TECHNOLOGIE · KarlsruheГермания
- KIWA NEDERLAND BV · ApeldoornНидерландия
- OSPEDALE SAN RAFFAELE SRL · MilanoИталия
- PANEPISTIMIO PATRON · RIO PATRASГърция
- POLITECNICO DI MILANO · MilanoИталия
- SIEMENS HEALTHCARE SL · MADRIDИспания
- SORBONNE UNIVERSITE · ParisФранция
- THE UNIVERSITY OF MANCHESTER · ManchesterОбединеното кралство
- UNICANCER · ParisФранция
- UNIVERSIDAD CARLOS III DE MADRID · Getafe (Madrid)Испания
- UNIVERSIDAD REY JUAN CARLOS · MostolesИспания
- UNIVERSITAET BERN · BernШвейцария
Връзки
Данни: CORDIS, © Европейски съюз